Skip to main content

Medartis Holding AG (MED.SW)

SIX Healthcare Medical - DevicesView data quality →
41.9Fair

ValueMarkers Composite Index

Top 8%#41,332 of 44,707

DCF data not available

Piotroski
5/9
Neutral
Beneish
-2.18
Investigate
Altman
2.84
Grey Zone
DCF Value
-
N/A
ROIC
0.2%
Low
P/E
121.1
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Medartis Holding AG (MED.SW) — VMCI valuation read

Medartis Holding AG (MED.SW) carries a VMCI composite of 42/100, 8 points below the Healthcare sector median of 50. Among mid-cap names, that gap places MED.SW in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The MED.SW insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads MED.SW trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 3.4x is the binding constraint on the bear case, the line to track on Medartis Holding AG's next 10-Q.

MED.SW held flat 0.0% over the trailing 7 days, with a +5.7% read on a 30-day basis.

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.

CEO: Matthias Schupp816 employeesCHwww.medartis.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in MED.SW’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.